Ten years of U.S. data suggest cholesterol-lowering statins are giving patients a license to pig out. Calorie and fat intake increased among statin users during the decade — an indication many patients might be abandoning heart-healthy lifestyles.
Heart experts who wrote new guidelines for preventing heart attacks and strokes are defending a formula that some doctors say overestimates risk for certain groups.
Usually being obese means a higher chance of developing health problems. But, a new study shows that it is possible to be fat and fit – and also to be at no greater risk for some chronic diseases.
Here’s another reason to know your blood type — it might be a clue to your risk of heart disease. People who have blood types A, B, or AB have a slightly higher risk of heart disease compared to those with type O.
Finally some good news about cholesterol and kids: A big government study shows that in the past decade, the proportion of children who have high cholesterol has fallen.
Should all U.S. children get tested for high cholesterol? Doctors are still debating that question months after a government-appointed panel recommended widespread screening that would lead to prescribing medicine for some kids.
Some North Texas researchers believe they have found a way to control obesity by manipulating molecules in the heart. Researchers at UT Southwestern have demonstrated, for the first time, that the heart can regulate energy balance.
Dr. Crystal Foster with Baylor Health Care System offers her medical insight on some of the latest health headlines.
Federal regulators have decided not to approve a new combination cholesterol drug made by Merck & Co., at least for now.
Federal health officials are adding new safety warnings about risks of memory loss and elevated blood sugar to statins, a widely prescribed group of cholesterol-lowering medications.
Every child should be tested for high cholesterol by age 11 so steps can be taken to prevent heart disease later on, a panel of doctors urged Friday in new advice that is sure to be controversial.
A drug that boosts people’s good cholesterol didn’t go on to prevent heart attacks or strokes, leading U.S. officials to abruptly halt a major study Thursday.